Normal levels of serum IGF-I: determinants and validity of current reference ranges.
Affiliation
Department of Endocrinology, Christie Hospital, Wilmslow Rd, Manchester M20 4BX, UK. georg.Brabant@Manchester.ac.ukIssue Date
2007
Metadata
Show full item recordAbstract
Insulin like growth factor I (IGF-I) represents the key marker for the evaluation of Growth hormone (GH) status. As a large number of determinants including age, gender, genetic factors, nutrition, and disease states influence IGF-I serum levels, accurate normative data are essential to translate patient data into diagnostic meaning or even use IGF-I levels for adequate monitoring of patients with an over- or under-active GH axis. Even though reference ranges have been developed in large cohorts of healthy subjects, the dependency of these data on a given assay technology argues for assay specific normative data for IGF-I.Citation
Normal levels of serum IGF-I: determinants and validity of current reference ranges. 2007, 10 (2):129-33 PituitaryJournal
PituitaryDOI
10.1007/s11102-007-0035-9PubMed ID
17487588Type
ArticleLanguage
enISSN
1386-341Xae974a485f413a2113503eed53cd6c53
10.1007/s11102-007-0035-9
Scopus Count
Collections
Related articles
- Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
- Authors: Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Müller J, Skakkebaek NE
- Issue date: 1997 Aug
- Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults.
- Authors: Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Bellone J, Camanni F, Ghigo E
- Issue date: 1998 Sep
- The IGF-I generation test revisited: a marker of GH sensitivity.
- Authors: Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG
- Issue date: 2001 Nov
- Establishment of reference values for endocrine tests. Part VII: growth hormone deficiency.
- Authors: Eskes SA, Tomasoa NB, Endert E, Geskus RB, Fliers E, Wiersinga WM
- Issue date: 2009 Apr
- Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
- Authors: Gravholt CH, Naeraa RW, Fisker S, Christiansen JS
- Issue date: 1997 Aug